Maryland · 86828

Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in Maryland

Maryland Medicare Avg
$61.43
2% below national avg
National Medicare Avg
$62.41
All states combined
Billed Charge (MD)
$160.00
What providers submit
Est. Commercial (MD)
$122.85
National avg: $139.79
Est. Cash / Self-Pay (MD)
$90.07
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

106
Services in MD
1
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Maryland

Provider Medicare Services
Johns Hopkins University $61.43 106

Maryland Pricing in Context

In Maryland, CPT code 86828 (Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens) carries an average Medicare payment of $61.43 — 2% below the national benchmark of $62.41. 1 providers across the state submitted claims for this procedure in 2023, performing 106 total services. Individual payments in MD ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Maryland is $160.00, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Maryland sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Maryland lands near $122.85, with self-pay cash prices typically around $90.07. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cost in Maryland?

The average Medicare payment for Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in Maryland is $61.43, which is 2% below the national average of $62.41. Providers in MD typically bill $160.00 for this procedure.

What does Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cost with insurance in Maryland?

With commercial insurance in Maryland, Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens costs an estimated $122.85. Without insurance, the estimated cash price is $90.07. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in Maryland?

1 providers in Maryland billed Medicare for Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in 2023, performing 106 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cheaper in Maryland than the national average?

Yes — Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens costs 2% below the national average in Maryland. The state average Medicare payment is $61.43 compared to $62.41 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial